Language: 简体中文 English
参会嘉宾

吕华

石药集团

更新时间:2020/9/7 18:32:44
吕华博士现任石药集团临床开发事业部转化医学高级总监,加入石药集团前曾在江苏恒瑞担任临床药理部总监,负责非肿瘤创新药物管线中临床药理工作。吕博士本科毕业于中国药科大学药物化学专业,2003年进入王广基院士的国家重点实验室攻读博士学位,博士期间主要从事中药的PK和PD研究。2010年进入美国纽约的西奈山医学院从事抗脑瘤药物PBPK的博士后研究,随后在西奈山医学院从事临床药理讲师工作。在2014年年初回国加入罗氏上海创新中心担任DMPK部门负责人,带领团队为罗氏中国项目研发提供DMPK专业支持。
Dr. Lv is senior director of Translational Medicine in CSPC, before joining CSPC, Dr. Lv was the director of Clinical Pharmacology Department from Jiangsu Hengrui Pharmaceutical Co., Ltd.. She led a CP group of 9 CP scientists and pharmacometrican to support all non-onc projects from pre IND to NDA in Hengrui. Dr. Lv graduated from China Pharmaceutical University with a bachelor's degree in medicinal chemistry. In 2003, she started her PhD training in National Key Laboratory of Pharmacokinetics, during which she mainly focused on PK/PD research of Traditional Chinese medicine. In 2010, she went to Mount Sinai School of Medicine in New York, USA, and for her postdoctoral research on PBPK modeling in anti brain tumor drugs. And then worked as a instructor in clinical pharmacology department in Mount Sinai. In early 2014, she returned to China and joined Roche Shanghai Innovation Center as the head of DMPK department, leading the team to support all projects in Roche China from early discovery to development phase.
距离大会开幕还有
  • 小时
  • 分钟
重要时间

   会议日期

   2020年9月25-27日

   网上注册截止日期

   2020年09月23日

   现场报到日期

   2020年09月25日